Gavi Offers to Phase Out Vaccines Containing Thimerosal in Bid to Unlock $600 Million in U.S. Funding

Gavi Offers to Phase Out Vaccines Containing Thimerosal in Bid to Unlock $600 Million in U.S. Funding
newstarget.com

Gavi Offers to Phase Out Vaccines Containing Thimerosal in Bid to Unlock $600 Million in U.S. Funding

Gavi, the international vaccine alliance, offered Thursday to accelerate its transition away from vaccines containing thimerosal, a mercury-based preservative, in an effort to secure $600 million in U.S. funding that Health Secretary Robert F. Kenned